Made in Oslo, the first ever Norwegian CAR T cell is now a fact.
Author Archive for: oslocancer
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 364 entries.
Entries by oslocancer
A second group of patients have been added to an ongoing phase II clinical study of a drug combination to treat lung cancer.
How can the voices of cancer patients be heard when evaluating new methods of treatment?
Students were taught about the chemistry behind developing cancer treatments in the Oslo Cancer Cluster Incubator.
Student Jørgen Amdim got to experience life as an orderly at the Radium Hospital.
A new study may potentially enable scientists to provide cancer immunotherapy that is cheaper, faster and more manageable.
The laboratories at Oslo Cancer Cluster Incubator are expanding to meet increasing demand from members.
Dr. Jon Amund Kyte at Oslo University Hospital aims to bring more and better clinical trials to Norway.
Targovax, one of the members of Oslo Cancer Cluster, has begun an expansion patient group in the clinical trial of a drug to treat skin cancer. The company Targovax is developing immune activators to target solid tumours that are difficult to treat. The drug in question, called ONCOS-102, is aimed at patients with malignant melanoma (skin […]
Vaccibody and Roche have started a new collaboration to investigate a drug combination for patients with advanced cervical cancer.
Contact Team >
Oslo Cancer Cluster Innovation Park opened in May 2015.
The Innovation Park brings together the oncology-value chain from basic research to industry within the Oslo-area.
Our vision is to create Europe's leading environment for education, research and industry within oncology, shortening the development time of new cancer treatments.